Can the duration of tuberculosis treatment be shortened with higher dosages of rifampicin?
作者信息
Dutta Noton K, Karakousis Petros C
机构信息
Department of Medicine, Center for Tuberculosis Research, Johns Hopkins University School of Medicine Baltimore, MD, USA.
Department of Medicine, Center for Tuberculosis Research, Johns Hopkins University School of Medicine Baltimore, MD, USA ; Department of International Health, Johns Hopkins Bloomberg School of Public Health Baltimore, MD, USA.
出版信息
Front Microbiol. 2015 Oct 14;6:1117. doi: 10.3389/fmicb.2015.01117. eCollection 2015.
Abstract
摘要
相似文献
1
Can the duration of tuberculosis treatment be shortened with higher dosages of rifampicin?增加利福平剂量能否缩短结核病的治疗疗程？
Front Microbiol. 2015 Oct 14;6:1117. doi: 10.3389/fmicb.2015.01117. eCollection 2015.
2
Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB.利福霉素类药物（利福平、利福布汀和利福喷汀）与异烟肼相比，用于预防有活动性结核病风险的HIV阴性人群患结核病。
Evid Based Child Health. 2014 Mar;9(1):169-294. doi: 10.1002/ebch.1962.
3
[The animal experimental study on rifampicin-dependent Mycobacterium tuberculosis].[利福平依赖型结核分枝杆菌的动物实验研究]
Zhonghua Jie He He Hu Xi Za Zhi. 2006 Sep;29(9):617-21.
4
5
Optimal doses of rifampicin in the standard drug regimen to shorten tuberculosis treatment duration and reduce relapse by eradicating persistent bacteria.优化标准药物治疗方案中的利福平剂量，通过消灭持续存在的细菌来缩短结核病治疗时间并降低复发率。
J Antimicrob Chemother. 2018 Mar 1;73(3):724-731. doi: 10.1093/jac/dkx467.
6
High-dose rifampicin kills persisters, shortens treatment duration, and reduces relapse rate in vitro and in vivo.高剂量利福平可杀死持留菌，缩短治疗时间，并降低体内外的复发率。
Front Microbiol. 2015 Jun 23;6:641. doi: 10.3389/fmicb.2015.00641. eCollection 2015.
7
Accumulation of rifampicin by Mycobacterium aurum, Mycobacterium smegmatis and Mycobacterium tuberculosis.金色分枝杆菌、耻垢分枝杆菌和结核分枝杆菌对利福平的摄取
J Antimicrob Chemother. 2000 Feb;45(2):159-65. doi: 10.1093/jac/45.2.159.
8
9
Evolution of rifampicin treatment for tuberculosis.利福平治疗结核病的演变。
Infect Genet Evol. 2019 Oct;74:103937. doi: 10.1016/j.meegid.2019.103937. Epub 2019 Jun 24.
10
The multistate tuberculosis pharmacometric model: a semi-mechanistic pharmacokinetic-pharmacodynamic model for studying drug effects in an acute tuberculosis mouse model.多州结核病药代动力学模型：一种用于研究急性结核病小鼠模型中药物效应的半机制药代动力学-药效学模型。
J Pharmacokinet Pharmacodyn. 2017 Apr;44(2):133-141. doi: 10.1007/s10928-017-9508-2. Epub 2017 Feb 15.
引用本文的文献
1
Commentary: Rifabutin Resistance Associated with Double Mutations in Gene in Isolates.评论：分离株中与基因双突变相关的利福布汀耐药性。
Front Microbiol. 2017 Nov 27;8:2274. doi: 10.3389/fmicb.2017.02274. eCollection 2017.
2
A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis.一种用于评估药物对巨噬细胞传代结核分枝杆菌疗效的高通量兼容检测方法。
J Vis Exp. 2017 Mar 24(121):55453. doi: 10.3791/55453.
3
Statin adjunctive therapy shortens the duration of TB treatment in mice.他汀类辅助治疗可缩短小鼠结核病治疗疗程。
J Antimicrob Chemother. 2016 Jun;71(6):1570-7. doi: 10.1093/jac/dkw014. Epub 2016 Feb 21.
本文引用的文献
1
High-dose rifampicin kills persisters, shortens treatment duration, and reduces relapse rate in vitro and in vivo.高剂量利福平可杀死持留菌，缩短治疗时间，并降低体内外的复发率。
Front Microbiol. 2015 Jun 23;6:641. doi: 10.3389/fmicb.2015.00641. eCollection 2015.
2
Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses.结核病病理学、微环境及治疗反应的异质性
Immunol Rev. 2015 Mar;264(1):288-307. doi: 10.1111/imr.12252.
3
Study of efflux pump gene expression in rifampicin-monoresistant Mycobacterium tuberculosis clinical isolates.利福平单耐药结核分枝杆菌临床分离株中外排泵基因表达的研究。
J Antibiot (Tokyo). 2015 Jul;68(7):431-5. doi: 10.1038/ja.2015.9. Epub 2015 Feb 18.
4
A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis.一项优化利福平剂量治疗结核病的剂量范围试验。
Am J Respir Crit Care Med. 2015 May 1;191(9):1058-65. doi: 10.1164/rccm.201407-1264OC.
5
Rifampicin and rifapentine significantly reduce concentrations of bedaquiline, a new anti-TB drug.利福平与利福喷汀可显著降低新型抗结核药物贝达喹啉的血药浓度。
J Antimicrob Chemother. 2015 Apr;70(4):1106-14. doi: 10.1093/jac/dku504. Epub 2014 Dec 21.
6
Could high-concentration rifampicin kill rifampicin-resistant M. tuberculosis? Rifampicin MIC test in rifampicin-resistant isolates from patients with osteoarticular tuberculosis.高浓度利福平能否杀死耐利福平的结核分枝杆菌？骨与关节结核患者耐利福平分离株的利福平MIC检测。
J Orthop Surg Res. 2014 Dec 3;9:124. doi: 10.1186/s13018-014-0124-1.
7
Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis.基于莫西沙星的四个月疗程用于治疗药物敏感型肺结核。
N Engl J Med. 2014 Oct 23;371(17):1577-87. doi: 10.1056/NEJMoa1407426. Epub 2014 Sep 7.
8
Population pharmacokinetics of rifapentine and desacetyl rifapentine in healthy volunteers: nonlinearities in clearance and bioavailability.利福喷汀和去乙酰利福喷汀在健康志愿者中的群体药代动力学：清除率和生物利用度的非线性特征
Antimicrob Agents Chemother. 2014 Jun;58(6):3035-42. doi: 10.1128/AAC.01918-13. Epub 2014 Mar 10.
9
Serum drug concentrations predictive of pulmonary tuberculosis outcomes.预测肺结核结局的血清药物浓度。
J Infect Dis. 2013 Nov 1;208(9):1464-73. doi: 10.1093/infdis/jit352. Epub 2013 Jul 29.
10
Optimization of the rifampin dosage to improve the therapeutic efficacy in tuberculosis treatment using a murine model.优化利福平剂量以提高小鼠模型中结核病治疗的疗效。
Am J Respir Crit Care Med. 2013 May 15;187(10):1127-34. doi: 10.1164/rccm.201207-1210OC.
Zotero 插件